Product image of Zutectra (Human Hepatitis B Immunoglobulin) supplied by GNH India

Zutectra

Active Ingredient:
Human Hepatitis B Immunoglobulin
Origin:
EU

Zutectra (Human Hepatitis B Immunoglobulin)

Zutectra is a human hepatitis B immunoglobulin used for post-exposure prophylaxis and long-term protection against hepatitis B virus. It provides passive immunity by delivering antibodies derived from plasma. Suitable for patients with insufficient vaccine response or exposure risk. Short-term protection for travelers or healthcare workers.

Manufacturer / TM Owner

Biotest Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zutectra is used to prevent hepatitis B infection after exposure, such as needlestick injuries or mucosal contact with infected blood. It is also prescribed for individuals who have not responded adequately to hepatitis B vaccination or require rapid immunity, such as before travel to high-risk areas. The medication provides temporary protection by supplying pre-formed antibodies.

Side Effects

  • Zutectra works by delivering antibodies that bind to the hepatitis B virus, helping the body neutralize the infection before it takes hold. Users may notice a reduction in anxiety about potential exposure after administration. The effects are temporary and do not provide permanent immunity like a vaccine.

Precautions & Warnings

  • Store Zutectra in a refrigerator at 2°C to 8°C and protect from light. Do not freeze or shake the vial. Administer only as directed by a healthcare professional. Report any signs of allergic reaction, such as swelling or difficulty breathing, immediately. Keep out of reach of children.

Avoid Interactions

  • Zutectra may interact with live vaccines, potentially reducing their effectiveness. Avoid receiving live vaccines for at least 3 months after administration. No known interactions with alcohol or common medications, but consult a healthcare provider before combining with other treatments. Immune response to other vaccines may be temporarily altered.

Frequently Asked Questions

Zutectra is used to prevent hepatitis B infection after exposure or in individuals with inadequate vaccine response.

Zutectra is given as a subcutaneous injection, typically under medical supervision.

Yes, it may be used for short-term protection against hepatitis B for travelers to high-risk areas.

Protection is temporary, typically lasting a few months, depending on exposure risk.

Consult a healthcare provider; use only if clearly needed and benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Hepatitis B Immunoglobulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT